MLICM
CLB icon

Metropolitan Life Insurance Company (MetLife)’s Core Laboratories CLB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,848
Closed -$48.6K – 433
2024
Q1 		$48.6K Hold
2,848
– – ﹤0.01% 1417
2023
Q4 		$50.3K Hold
2,848
– – ﹤0.01% 1444
2023
Q3 		$68.4K Buy
2,848
+283
+11% +$6.95K ﹤0.01% 1218
2023
Q2 		$59.6K Buy
+2,565
New +$58K ﹤0.01% 1319
2020
Q2 		– Sell
-10,741
Closed -$111K – 2555
2020
Q1 		$111K Sell
10,741
-641
-6% -$17.9K ﹤0.01% 1973
2019
Q4 		$429K Buy
11,382
+75
+0.7% +$3.37K 0.01% 1428
2019
Q3 		$527K Sell
11,307
-299
-3% -$13.9K 0.01% 1257
2019
Q2 		$607K Buy
11,606
+13
+0.1% +$763 0.01% 1180
2019
Q1 		$799K Buy
+11,593
New +$777K 0.01% 1009

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CLB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 2,848 shares — an estimated $48.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CLB in Q1 2019 and held it in 9 quarters. The position peaked at $799K in Q1 2019. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,848 Core Laboratories shares in Q2 2024, an estimated $48.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Core Laboratories in Q1 2019 and held it in 9 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Core Laboratories position peaked at $799K in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.